BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19098321)

  • 1. Nucleotide oligomerization domain-2 (NOD2)-induced uveitis: dependence on IFN-gamma.
    Rosenzweig HL; Kawaguchi T; Martin TM; Planck SR; Davey MP; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1739-45. PubMed ID: 19098321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis.
    Rosenzweig HL; Martin TM; Jann MM; Planck SR; Davey MP; Kobayashi K; Flavell RA; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1518-24. PubMed ID: 18385071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant interleukin-1 signalling does not increase susceptibility of mice to NOD2-dependent uveitis.
    Lee EJ; Allensworth JJ; Clowers JS; Rosenzweig HL
    Clin Exp Ophthalmol; 2015; 43(4):349-57. PubMed ID: 25255917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of NOD2 in vivo induces IL-1beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling.
    Rosenzweig HL; Martin TM; Planck SR; Galster K; Jann MM; Davey MP; Kobayashi K; Flavell RA; Rosenbaum JT
    J Leukoc Biol; 2008 Aug; 84(2):529-36. PubMed ID: 18495787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation.
    Castellaneta A; Sumpter TL; Chen L; Tokita D; Thomson AW
    J Immunol; 2009 Dec; 183(11):6922-32. PubMed ID: 19890047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in mice.
    Rosenzweig HL; Galster K; Vance EE; Ensign-Lewis J; Nunez G; Davey MP; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4106-12. PubMed ID: 21296813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
    Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
    Front Immunol; 2022; 13():988862. PubMed ID: 36189261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
    Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
    J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis.
    Rosenzweig HL; Jann MM; Glant TT; Martin TM; Planck SR; van Eden W; van Kooten PJ; Flavell RA; Kobayashi KS; Rosenbaum JT; Davey MP
    J Leukoc Biol; 2009 Apr; 85(4):711-8. PubMed ID: 19129483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD2: a potential target for regulating liver injury.
    Body-Malapel M; Dharancy S; Berrebi D; Louvet A; Hugot JP; Philpott DJ; Giovannini M; Chareyre F; Pages G; Gantier E; Girardin SE; Garcia I; Hudault S; Conti F; Sansonetti PJ; Chamaillard M; Desreumaux P; Dubuquoy L; Mathurin P
    Lab Invest; 2008 Mar; 88(3):318-27. PubMed ID: 18227809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOD1 expression in the eye and functional contribution to IL-1beta-dependent ocular inflammation in mice.
    Rosenzweig HL; Galster KT; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1746-53. PubMed ID: 19074813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal astrocytes pretreated with NOD2 and TLR2 ligands activate uveitogenic T cells.
    Jiang G; Sun D; Kaplan HJ; Shao H
    PLoS One; 2012; 7(7):e40510. PubMed ID: 22808176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2.
    Marina-García N; Franchi L; Kim YG; Miller D; McDonald C; Boons GJ; Núñez G
    J Immunol; 2008 Mar; 180(6):4050-7. PubMed ID: 18322214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection.
    Coulombe F; Fiola S; Akira S; Cormier Y; Gosselin J
    PLoS One; 2012; 7(5):e36734. PubMed ID: 22590599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide.
    Davey MP; Martin TM; Planck SR; Lee J; Zamora D; Rosenbaum JT
    Microvasc Res; 2006 Mar; 71(2):103-7. PubMed ID: 16414084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pluripotent stem cell models of Blau syndrome reveal an IFN-γ-dependent inflammatory response in macrophages.
    Takada S; Kambe N; Kawasaki Y; Niwa A; Honda-Ozaki F; Kobayashi K; Osawa M; Nagahashi A; Semi K; Hotta A; Asaka I; Yamada Y; Nishikomori R; Heike T; Matsue H; Nakahata T; Saito MK
    J Allergy Clin Immunol; 2018 Jan; 141(1):339-349.e11. PubMed ID: 28587749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nod2-Nodosome in a Cell-Free System: Implications in Pathogenesis and Drug Discovery for Blau Syndrome and Early-Onset Sarcoidosis.
    Iwasaki T; Kaneko N; Ito Y; Takeda H; Sawasaki T; Heike T; Migita K; Agematsu K; Kawakami A; Morikawa S; Mokuda S; Kurata M; Masumoto J
    ScientificWorldJournal; 2016; 2016():2597376. PubMed ID: 27403452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3.
    Pan Q; Mathison J; Fearns C; Kravchenko VV; Da Silva Correia J; Hoffman HM; Kobayashi KS; Bertin J; Grant EP; Coyle AJ; Sutterwala FS; Ogura Y; Flavell RA; Ulevitch RJ
    J Leukoc Biol; 2007 Jul; 82(1):177-83. PubMed ID: 17403772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.